As of Dec 26, 2024, the CRGX stock has a P/E ratio of 0.19. The calculation is based on the latest EPS of $78.85 and the stock price of $14.89 per share.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
When compared to its peer stocks AMGN and GILD, CRGX's PE ratio is lower. CARGO Therapeutics is currently trading at a lower PE ratio (0.19) than its peers average of 35.63.
Stock name | PE ratio | Market cap |
---|---|---|
CRGX CARGO Therapeutics Inc | 0.19 | $685.35M |
BIIB Biogen Inc | 13.49 | $21.84B |
REGN Regeneron Pharmaceuticals Inc | 16.57 | $78.76B |
AMGN Amgen Inc | 33.36 | $141.47B |
SRPT Sarepta Therapeutics Inc | 79.08 | $11.78B |
GILD Gilead Sciences Inc | 944.1 | $117.66B |
VRTX Vertex Pharmaceuticals Inc | N/A | $105.75B |
ALNY Alnylam Pharmaceuticals Inc | N/A | $31.28B |
MRNA Moderna Inc | N/A | $15.56B |
NVAX Novavax Inc | N/A | $1.36B |
As of Dec 26, 2024, CRGX stock has a price to earnings ratio of 0.19.
CRGX's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Dec 26, 2024), CARGO Therapeutics's share price is $14.89. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $78.85. Therefore, CARGO Therapeutics's price to earnings ratio for today is 0.19. PE RATIO(0.19) = STOCK PRICE($14.89) / TTM EPS($78.85)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.